Beneficial Effects of Angiotensin Converting Enzyme Inhibition on Renal Function in Patients With Diabetic Nephropathy.

BMJ
doi 10.1136/bmj.293.6553.1028
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Characterization of Renal Angiotensin-Converting Enzyme 2 in Diabetic Nephropathy

Hypertension
Internal Medicine
2003English

Angiotensin Converting Enzyme Inhibitors and Diabetic Nephropathy.

BMJ
1992English

Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2009English

Angiotensin-I Converting Enzyme Polymorphism and Diabetic Nephropathy in North India

International Journal of Human Genetics
Genetics
2005English

Angiotensin-Converting Enzyme Inhibition Potentiates Angiotensin II Type 1 Receptor Effects on Renal Bradykinin and cGMP

Hypertension
Internal Medicine
2001English

Converting Enzyme Inhibition and Renal Tissue Angiotensin II in the Rat

Hypertension
Internal Medicine
1994English

Polymorphism of Angiotensin-Converting Enzyme (Rs4340) and Diabetic Nephropathy in Caucasians With Type 2 Diabetes Mellitus

Balkan Journal of Medical Genetics
Genetics
2016English

Increased Urinary Angiotensin-Converting Enzyme 2 in Renal Transplant Patients With Diabetes

PLoS ONE
Multidisciplinary
2012English

Effects of Angiotensin Converting Enzyme Inhibitor and Calcium Antagonist on Endothelial Function in Patients With Essential Hypertension.

Hypertension Research
Internal MedicineCardiovascular MedicinePhysiologyCardiology
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy